MedTrace Logo

Contribution Of Cognitivo-Behavorial Therapy In Shoulder Apprehension

NCT05767957 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2023-03-14

No results posted yet for this study

Summary

Randomized controlled double-blind study aimed at studying the contribution of cognitive-behavioral therapy in the treatment of shoulder apprehension. Comparison of 2 physiotherapy techniques in the context of shoulder instability.

Control group: rehabilitation physiotherapy by physiotherapist using conventional technique alone.

Intervention group: rehabilitation physiotherapy by physiotherapist according to conventional technique, with the addition of techniques from cognitive-behavioral therapies.

Conditions

  • Shoulder Dislocation
  • Shoulder Instability

Interventions

OTHER

Rehabilitation physiotherapy

Rehabilitation physiotherapy by physiotherapist using conventional technique alone.

OTHER

Cognitive-behavioral therapies in addition to rehabilitation physiotherapy

Rehabilitation physiotherapy by physiotherapist according to conventional technique, with the addition of techniques from cognitive-behavioral therapies.

Sponsors & Collaborators

  • Gregory Cunningham

    collaborator UNKNOWN

  • Alexandre Laedermann

    collaborator UNKNOWN

  • Benoît Borner

    collaborator UNKNOWN

  • Yannick Thilby

    collaborator UNKNOWN

  • Suzanne Gard

    collaborator UNKNOWN

  • Centre Epaule Coude CEPCO

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-01-31
Completion
2024-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05767957 on ClinicalTrials.gov